TL;DR
ALA-PDT may be considered as a viable treatment option for women with type 3 TZ, persistent LSIL and high-risk HPV infection, and its benefit for patients with various clinical risk factors is suggested.
AI-generated by Semantic Scholar
Authors
Ruizhe Chen, Junfen Xu, Chun Ye, Lingjia Lu, Ying Li, Lingfang Wang, Xiaodong Cheng, Yunfeng Fu